Articles
Page 4 of 19
-
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P237
-
Abstract withdrawn
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P214 -
Efficiency of HIV-1 PR-RT genotyping is not impacted by co-infection with HCV
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P212 -
No impact of IL28B polymorphisms on liver enzymes in patients coinfected with HIV and HCV
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P206 -
Role of HCV infection in the development of carotid atherosclerosis in a cohort of HIV-infected patients
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P204 -
PK/PD modeling supports the dose-escalation decision in VIKING
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P182 -
Pharmacokinetics of plasma lopinavir/ritonavir following the administration of 400/100, 200/150, and 200/50 mg twice daily in HIV-negative volunteers
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P180 -
SLCO3A1 expression is a major determinant of atazanavir PBMC penetration in HIV-infected patients
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P178 -
Pharmacokinetics of lamivudine, abacavir and zidovudine administered twice daily as syrups versus scored tablets in HIV-1-infected Ugandan children
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P176 -
The impact of late presentation: analysis of a cohort of 313 Portuguese patients
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P174 -
Adherence to HIV treatment guidelines for initiation of antiretroviral therapy in Australia
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P172 -
Audit of telephone HIV clinics: effective and acceptable
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P170 -
Offering HIV testing in an emergency admission unit in Newcastle upon Tyne, UK — a pilot audit study
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P168 -
Genotype testing in HIV-infected pregnant women
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P145 -
Pro-viral DNA and antiretroviral treatment simplification
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P143 -
Molecular epidemiology of antiretroviral resistance in therapy-experienced HIV-1 patients in Cuba (2009)
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P141 -
Prevalence of HIV drug-resistance mutations in HIV-infected Mexican patients heavily experienced to antiretroviral therapy
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P139 -
Abstract withdrawn
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P137 -
High levels of polymorphisms related to raltegravir resistance among raltegravir-naïve individuals in Brazil
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P135 -
Darunavir resistance spectrum in darunavir-na#239;ve patients harboring virological failure to antiretroviral therapy
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P133 -
Clinical application of genotypic co-receptor tropism testing from viral RNA and proviral DNA: week 24 analysis of the Berlin maraviroc cohort
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P129 -
Raltegravir-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: implications for clinical practice and patient safety
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P110 -
Behaviour and attitudes in HIV (BEAHIV): a national survey study to examine the level of agreement between physicians and patients in symptom reporting
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P106 -
Tenofovir use is associated with low vitamin D levels in a Spanish HIV cohort
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P104 -
The serum level of 25-OH vitamin D and Th1 cytokine pattern in HIV infection versus hepatitis C virus infection and hepatitis B virus infection
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P102 -
Rates of bone fractures in a cohort of HIV-infected adults in the UK
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P100 -
Hepatotoxicity in patients co-infected with HIV and tuberculosis while receiving NNRTI-based antiretroviral regimen and rifampicin
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P90 -
The 10 year safety and efficacy of tenofovir disoproxil fumarate (TDF)-containing once-daily highly active antiretroviral therapy (HAART)
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P86 -
Switching from Kivexa + efavirenz to Atripla reduces total cholesterol in hypercholesterolemic subjects: final results of a 24-week, randomized study
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P80 -
Altered phosphate metabolism in HIV-1-infected patients: another feature of metabolic syndrome?
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P78 -
Nutritional status in HIV-infected patients using Changi's mini nutritional assessment
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P76 -
Switching to dual therapy with darunavir/ritonavir and etravirine: a simplification strategy
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P51 -
Switch to once or twice daily unboosted atazanavir in a cohort of stable HIV patients: strong differences in drug exposure and virological outcome
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P47 -
48-week efficacy and safety of transitioning virologically stable HIV-1 patients from nevirapine IR 200 mg BID to nevirapine XR 400 mg QD (TRANxITION)
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P45 -
Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O43 -
What affects the bone in our HIV-positive patients?
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O41 -
Efficacy of once daily darunavir/ritonavir 800/100 mg in PI/r-experienced HIV-1 infected patients with suppressed HIV-1 replication: the RADAR study
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P41 -
Fatal and non-fatal AIDS and non-AIDS events in HIV-1 infected patients with high CD4 counts
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O39 -
Immunologic impact of maraviroc in clinical practice of a university hospital
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P39 -
Temporal trend of the first prescription of nevirapine: the ANRS CO3 Aquitaine Cohort, 1997-2008
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P37 -
HIV/HAART and the brain — what's going on?
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O35 -
0315. The pharmacokinetic and safety profile of raltegravir and ribavirin, when dosed separately and together, in healthy volunteers
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O33 -
0313. Hepatitis C — feedback from the Consensus Conference on the Management of Acute Hepatitis C (AHC) in Paris, May 2010
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O31 -
0311. Hepatitis C new drugs
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O29 -
0233. Impact on life expectancy of late diagnosis and treatment of HIV-1 infected individuals: UK CHIC
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):O27 -
Insights into antiretroviral treatment changes in previously naïve patients: results of a Portuguese cohort
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P14 -
Efficacy and safety of TDF/FTC-containing, first-line HAART in clinical practice: 3-year data from the German outpatient cohort
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P12 -
Comparing the effectiveness of efavirenz and nevirapine for first-line antiretroviral treatment amongst an adult treatment cohort from South Africa
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P10 -
HRQoL improves in treatment-naïve HIV-1 subjects initiated on lopinavir/ritonavir (LPV/r) with raltegravir (RAL) or tenofovir/emtricitabine (TDF/FTC)
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P8 -
5-year safety and efficacy of the once-daily antiretroviral regimen of efavirenz (EFV)/emtricitabine (FTC)/tenofovir disoproxil fumarate (TDF)
Citation: Journal of the International AIDS Society 2010 13(Suppl 4):P6